Investors | Verici Dx

Home » Investors

FOND DU LAC

QUIT QUI OC

Lorem ipsum dolor sit amet consectetur adipiscing elit.

Introduction

At Verici Dx, we believe our unique approach to developing leading-edge tests for personalized patient and organ response risk assessment has real impact in medical management for improved patient outcomes and positions us for continued growth and market leadership. This section is your comprehensive resource for understanding our financial performance, strategic vision, and commitment to responsible growth. We are transparent in our reporting and committed to building lasting value for our shareholders.

This area of the web site contains all information which is required to be disclosed in accordance with the AIM Rule 26.

Description of the business	see Company profile
Names of the directors, biographical details and responsibilities	see Board of Directors
Corporate governance	see Corporate governance
Shareholder Information UK City Code on Takeovers and Mergers Other exchanges and trading platforms Number of AIM securities in issue Significant shareholdings Director shareholdings Shares not in public hands Restrictions in transfer of AIM Securities	see Shareholder Centre
Financial information	see Annual & Interim reports
Company announcements	see Company announcements
Documents Admission Document Articles of Association Notice of Meetings	see Documents
Advisors	see Company information